SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-07-001113
Filing Date
2007-04-24
Accepted
2007-04-24 17:27:11
Documents
14
Period of Report
2007-06-08
Effectiveness Date
2007-04-24

Document Format Files

Seq Description Document Type Size
1 NOTICE OF PROXY STATEMENT regeneron_nps.htm DEF 14A 525261
2 GRAPHIC regeneron_nps1x1x1.jpg GRAPHIC 15396
3 GRAPHIC regeneron_nps1x1x2.jpg GRAPHIC 5806
4 GRAPHIC regeneron_nps1x3x1.jpg GRAPHIC 6922
5 GRAPHIC regeneron_nps1x7x1.jpg GRAPHIC 8537
6 GRAPHIC regeneron_nps2x1x1.jpg GRAPHIC 9435
7 GRAPHIC regeneron_nps2x1x2.jpg GRAPHIC 8856
8 GRAPHIC regeneron_nps2x1x3.jpg GRAPHIC 8640
9 GRAPHIC regeneron_nps2x1x4.jpg GRAPHIC 8489
10 GRAPHIC regeneron_nps2x2x1.jpg GRAPHIC 8985
11 GRAPHIC regeneron_nps2x2x2.jpg GRAPHIC 8903
12 GRAPHIC regeneron_nps2x2x3.jpg GRAPHIC 9033
13 GRAPHIC regeneron_nps2x2x4.jpg GRAPHIC 8751
14 GRAPHIC regeneron_nps2x2x5.jpg GRAPHIC 8916
  Complete submission text file 0001206774-07-001113.txt   689410
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19034 | Film No.: 07785436
SIC: 2834 Pharmaceutical Preparations